Rasch-built overall disability scale for POEMS syndrome (POEMS-RODS).

J Peripher Nerv Syst

Queen Square Centre for Neuromuscular Diseases, National Hospital of Neurology and Neurosurgery, Queen Square, University College London Hospitals NHS Foundation Trust, London, UK.

Published: December 2022

AI Article Synopsis

  • Patient-reported outcome measures can effectively gauge disease severity and are meaningful for patients' lives, particularly in complex disorders like POEMS, which affects multiple body systems and causes disabling neuropathy.
  • The research introduces a new scale, the Rasch-built Overall Disability Scale (POEMS-RODS), specifically designed for POEMS, created from a preliminary questionnaire which underwent thorough testing and refinement.
  • The final version of the POEMS-RODS includes 23 relevant items that show reliable results, but further international studies are needed to verify its effectiveness and adaptability in different populations.

Article Abstract

Patient-reported outcome measures engage patients in disease severity measurement and the metrics reported can be meaningful to their lives. The Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal protein and Skin changes syndrome (POEMS) is a complex multisystem disorder with disabling neuropathy which is distinct from other acquired inflammatory neuropathies. No current POEMS-specific validated disability scales exist. To address this, we have produced a Rasch-built overall disability scale (RODS) specific to POEMS. A 146-item preliminary questionnaire containing relevant activity and participation items for neuropathic disability was applied to 49 clinically stable patients with POEMS from the UK national POEMS cohort. A total of 123 items not fulfilling Rasch model expectations were sequentially removed. The final 23-item POEMS-RODS fulfilled Rasch model expectations and showed acceptable test-retest reliability. The 23-item POEMS-RODS is a disease-specific patient-reported outcome measure able to detect activity limitations within the range of ability demonstrated by the UK POEMS cohort. Larger international studies are needed to confirm the broader applicability and responsiveness of this scale in other countries.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092098PMC
http://dx.doi.org/10.1111/jns.12516DOI Listing

Publication Analysis

Top Keywords

rasch-built disability
8
disability scale
8
patient-reported outcome
8
poems cohort
8
rasch model
8
model expectations
8
23-item poems-rods
8
poems
6
scale poems
4
poems syndrome
4

Similar Publications

Background: Chronic immune-mediated neuropathies are clinically heterogeneous and require regular, objective, and multidimensional monitoring to individualize treatment. However, established outcome measures are insufficient regarding measurement quality criteria (e.g.

View Article and Find Full Text PDF

Background And Aims: The Inflammatory Rasch-built Overall Disability Scale (I-RODS) is an effective activity measure for use in inflammatory peripheral neuropathy. The aim of this study was to validate the Korean version of the I-RODS in patients with chronic inflammatory demyelinating polyneuropathy (CIDP), Guillain-Barré syndrome (GBS), anti-myelin-associated glycoprotein (MAG) neuropathy, and autoimmune nodopathy.

Methods: A total of 120 patients underwent clinical evaluations, which included the I-RODS, Inflammatory Neuropathy Cause and Treatment (INCAT) assessment, and Jamar grip strength (kg) measurement.

View Article and Find Full Text PDF

Background: Despite standard-of-care treatment, therapeutic outcomes in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are often incomplete. We aimed to evaluate the impact of clinical and therapeutic factors on long-term disability in CIDP, from cohorts from Korea and the UK.

Methods: We conducted a retrospective multicenter cohort study of 144 patients with CIDP.

View Article and Find Full Text PDF
Article Synopsis
  • ALS is a progressive neurodegenerative disease, with its functional decline typically assessed using the ALS Functional Rating Scale-Revised (ALSFRS-R).
  • The study focused on translating and validating the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) into Spanish for Spanish-speaking individuals with ALS.
  • Results showed that the Spanish ROADS has excellent reliability and a strong correlation with the ALSFRS-R, making it a valid tool for measuring functional disability in this population.
View Article and Find Full Text PDF

Background: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an autoimmune disease of the peripheral nervous system that can lead to severe disability from muscle weakness and sensory disturbances. Around a third of patients do not respond to currently available treatments, and many patients with a partial response have residual neurological impairment, highlighting the need for effective alternatives. Efgartigimod alfa, a human IgG1 antibody Fc fragment, has demonstrated efficacy and safety in patients with generalised myasthenia gravis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!